HomeCRBP • NASDAQ
add
Corbus Pharmaceuticals Holdings Inc
Previous close
$7.21
Day range
$7.22 - $7.41
Year range
$4.64 - $61.90
Market cap
89.82M USD
Avg Volume
161.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.02M | -21.86% |
Net income | -16.98M | -146.09% |
Net profit margin | — | — |
Earnings per share | -1.39 | -67.47% |
EBITDA | -18.58M | -96.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 132.79M | 10.56% |
Total assets | 139.93M | 11.28% |
Total liabilities | 12.82M | -55.44% |
Total equity | 127.11M | — |
Shares outstanding | 12.24M | — |
Price to book | 0.69 | — |
Return on assets | -31.54% | — |
Return on capital | -33.85% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -16.98M | -146.09% |
Cash from operations | -16.42M | -106.11% |
Cash from investing | 18.12M | 118.45% |
Cash from financing | — | — |
Net change in cash | 1.70M | 349.08% |
Free cash flow | -10.77M | -55.45% |
About
Founded
Jan 1, 2009
Website
Employees
28